Singapore investment company Temasek has acquired a 10.16 per cent equity stake in Intas Pharmaceuticals by way of secondary purchase of shares from private equity investor ChrysCapital.
Binish Chudgar, Vice Chairman and Managing Director, Intas Pharmaceuticals said, “ChrysCapital has been a valuable partner for Intas over the years. We are delighted to have lived up to the expectation of ChrysCapital and now look forward to welcoming a globally reputed investor like Temasek to enable Intas to reach greater heights in the years to come.”
Sanjiv Kaul, Managing Director, ChrysCapital said, “Intas has been an excellent investment for ChrysCapital with the company having grown revenues at 27 per cent CAGR since its investment in CY06. ChrysCapital reaffirmed its faith in the company with a fresh Rs 300-crores investment from a separate fund in CY12.”
EP News Bureau – Mumbai
- Advertisement -